Image source: Pfizer, Inc.After reporting rosy first-quarter financials and increasing its outlook for the year, Pfizer (NYSE: PFE) shares are trading higher. Investors wondering if Pfizer's shares should be bought or sold on this news might want to consider these nine numbers, each of which offers additional insight into whether the company is worth owning in your portfolio.Continue reading